- Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
- Galera Adopts Limited Duration Stockholder Rights Agreement
- Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
- Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
- Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
- Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
- Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
- Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0813 |
---|---|
High | 0.0998 |
Low | 0.065 |
Bid | -- |
Offer | -- |
Previous close | 0.083 |
Average volume | 668.61k |
---|---|
Shares outstanding | 54.39m |
Free float | 34.73m |
P/E (TTM) | -- |
Market cap | 4.60m USD |
EPS (TTM) | -0.9971 USD |
Data delayed at least 15 minutes, as of Jun 21 2024 20:50 BST.
More ▼